Pacific Wealth Strategies Group, Inc. Crispr Therapeutics Ag Transaction History

Pacific Wealth Strategies Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$110.2 - $156.64 $171,361 - $243,575	-1,555 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$100.84 - $161.89 $156,806 - $251,738	1,555 New	1,555 $252,000
Q1 2021 Apr 26, 2021	SELL	$110.72 - $210.04 $163,201 - $309,598	-1,474 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$79.67 - $173.23 $117,433 - $255,341	1,474 New	1,474 $286,000

523

57.9M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.54B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Pacific Wealth Strategies Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacific Wealth Strategies Group, Inc. with notifications on news.